IGF1 and type 2 diabetes mellitus: The greater angiogenic potential of T2DM–BMMSCs secretome may reflect the interactive actions of multiple bioactive mediators (including IGF‐1, LTBP1 and LTBP2) which may alter the functions of endothelial cells, key players in diabetic vascular complications 46.